International invited Speakers:

• Professor Ruedi Aebersold, Institute for Systems Biology, Switzerland
• Professor Seth Grant, Wellcome Trust Sanger Institute, Cambridge
• Dr Michael Pfaffl, Technical University, Munich
• Associate Professor Thomas Schmittgen, Ohio State University

Quantitative Genomics Workshop Sponsor: Corbett Research

Quantitative Genomics Workshop

Workshop Session 1

• Michael Pfaffl, Technical University, Munich
  Quantification of gene expression by real-time qRT-PCR
• Kristina Warton, Corbett  Research, Sydney
  Improvements to RNA extraction from formaldehyde fixed tissues
• Mark Jones, University of Western Sydney
  Applications of Direct Real Time PCR on Lymphocytes.
• Keith Stanley, Corbett  Research, Sydney
  Highly multiplexed SyBr green qPCR of breast cancer genes

Workshop Session 2

• Paul Pilowsky, University of Sydney
  Quantitation of neurotransmitter-related gene expression in the brain stem.
• Brant Bassam, Corbett  Research, Melbourne
  Assay Design for Real-Time PCR
• Valin Reja, Corbett Research, Sydney
  High resolution melt analysis
• Peter Williamson, University of Sydney
  The use of Real-Time PCR in a comparative genomics Programme
• Panel Discussion - Chair: Keith Stanley

Session 3: Victorian Proteomics Consortia Proteomics Session - Sponsored by: IIRD, Victorian State Government

• Ruedi Aebersold, Institute for Systems Biology, Vancouver, Canada
  Quantitative Proteomics and Systems Biology
• Kevin Downard, University of Sydney
  Flu takes flight: Influenza surveillance by mass spectrometry
• Jeff Gorman, IMB, Queensland
  Multidimensional Mass Spectrometric Analyses of Regulatory Post-Translational Modifications of Proteins
• Anthony Purcell, Bio21 Molecular Science and Biotechnology Institute, Melbourne
  Antigen post-translational modification – insights into the targets of the elusive autoreactive T cell!

Session 4: Immunology

• Chris Goodnow, APF, JCSMR, Canberra
  Controlled variation of the mammalian genome: the rosetta stone for decoding genome - phenome programming
• Jose Varghese, CSIRO
  In silico screening of drug targets and the Australian Synchrotron

Session 5: Biotechnology drivers & Commercialisation

• David Blake, BIMA, Melbourne
  Biotech drivers
• Rowan Gilmore, Australian Institute for Commercialisation
  The Road from Discovery to Market
• Richard Wettenhall, Bio21 Molecular Sciences and Biotechnology Institute, Melbourne
  Integrating research innovation, commercialisation and industry engagement in the new Bio21 Institute
• Silviu Itescu, Columbia University, NY
  Commercialisation of adult stem cells

Session 6: Genome wide studies and Systems Biology

• Malcolm McConnville, Bio21 Molecular Sciences and Biotechnology Institute, Melbourne
  Metabolomics and the Identification of new metabolic pathways in human pathogens
• Peter Hunter, Bioengineering Institute, University of Auckland
  Multiscale modelling and the Physiome Project
• Sean Grimmond, IMB, University of Queensland
  Computational and genomic characterization of signal transduction networks

Session 7: Neurobiology

• Seth Grant, Wellcome Trust Sanger Institute, Hinxton, Cambridge
  From Genes to Cognition
• Colin Masters, The University of Melbourne
  Pathways towards drug development in Alzheimer's disease
• Phil Robinson, Children's Medical Research Institute, Sydney
  Mass Spectrometry Approaches to Phosphorylation Sites in Endocytic Proteins at the Synapse

Session 8: Gene expression and knockdown - Sponsored by: Antisense Therapeutics Limited

• Andrew Holloway, Peter MacCallum Cancer Centre, Melbourne
  A systematic analysis of microarray platform accuracy
• Greg Arndt, Johnson & Johnson Research
  Gene knockdown using long complimentary RNAs
• Nick Dean, ISIS, California
  Antisense approaches to gene therapy

Session 9: Cancer

• Thomas Schmittgen, College of Pharmacy Ohio State University
  Real-time expression profiling of microRNAs in cancer
• Michelle Haber, Children's Cancer Institute Australia for Medical Research
  Childhood neuroblastoma: From target identification and validation through to drug discovery
• Robin Anderson, Peter MacCallum Cancer Centre, Melbourne
  A search for the genes that regulate breast cancer metastasis
• Alex Dobrovic, Peter MacCallum Cancer Centre, Melbourne
  Towards pharmaco-epigenomics: profiling DNA repair in cancer cell lines using high throughput quantitative RT-PCR